冠状动脉钙化检测:过早、过晚与过频
本文为JAMA Cardiology观点文章,讨论冠状动脉钙化(CAC)评分在初级预防降脂决策中的适用时机。作者提出三类应省略或推迟CAC检测的临床情境:检测过早、检测过晚、重复过频,强调CAC评分的价值取决于临床背景,需结合患者年龄、危险因素与动脉粥样硬化自然史解读。
要点
- CAC评分用于中级风险且他汀启动存在不确定性者的初级预防决策。
- 年轻高危成人即使CAC为0仍可能有较高终生心血管风险,检测可能过早。
- 老年人短期获益有限或已用降脂药,CAC评分价值下降,检测可能过晚。
核心结论
- CAC检测仅在合适的临床背景下才有用,需识别检测过早、过晚或过频的情境以优化其临床效用。
研究设计与样本
- 观点文章,围绕CAC评分在初级预防降脂决策中的应用,提出3类临床情境以促进医患风险讨论。
主要发现
- 年轻高危成人即使CAC为0仍可能面临升高的终生心血管病风险。
- 老年人短期时间范围内可能看不到预期获益,或已在服用降脂治疗,使CAC评分价值降低。
- 将CAC评分纳入降脂启动决策需理解患者危险因素(包括年龄)及动脉粥样硬化与相关事件的自然史。
关键数值与推荐
- 最新胆固醇指南建议:对中级风险且他汀启动存在不确定性者,用CT测量CAC评分以辅助初级预防决策。
临床怎么用
- 在医患风险讨论中,先评估患者年龄、危险因素与降脂治疗状态,再判断CAC检测能否提供有临床价值的信息,避免过早、过晚或过频检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Traditional risk factors, enhancing factors, and risk scores help clinicians assess atherosclerotic cardiovascular disease (ASCVD) risk for primary prevention. The latest cholesterol guidelines suggest measuring coronary artery calcium (CAC) score by computed tomography (CT) in those at intermediate risk when there is uncertainty about statin initiation for primary prevention. CAC testing can improve both risk estimation and adherence to cardiovascular risk-reducing behaviors. OBSERVATIONS: As measuring CAC score has become more widely available, this article focuses on 3 situations where CAC testing may be omitted or deferred until a time when CAC testing can provide clinically useful information. Three clinical scenarios to facilitate the clinician-patient risk discussion are as follows: (1) when CAC testing is too early, (2) when CAC testing is too late, and (3) when CAC testing is repeated too often. The timing of CAC testing sits within the decision point of lipid-lowering therapy use. High-risk young adults may face an elevated lifetime risk of cardiovascular disease despite a CAC level of 0, whereas older adults may not see an expected benefit over a short time horizon or may already be taking lipid-lowering therapy, rendering a CAC score less valuable. Integrating a CAC score into the decision to initiate lipid-lowering therapy requires understanding of a patient's risk factors, including age, as well as the natural history of atherosclerosis and related events. CONCLUSIONS AND RELEVANCE: These clinical scenarios reflect when consideration of CAC score is of use and when it is not. Although CAC testing is becoming more widely available and sought after by clinicians and patients alike, it is only as useful as the clinical context. Understanding when assessing CAC score is too early to effectively rule out risk, too late to influence decisions, or too often to yield clinically relevant information provides important insights that optimize the clinical utility of this potentially valuable prognostic tool.
引用
- Zheutlin AR, Chokshi AK, Wilkins JT, et al. Coronary Artery Calcium Testing-Too Early, Too Late, Too Often. JAMA Cardiol. 2025. PMID: 40042828. doi:10.1001/jamacardio.2024.5644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。